BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 21177182)

  • 1. [Expression of c-myb in reflux esophagitis, Barrett esophagus and esophageal adenocarcinoma].
    Ren CR; Dong L; Guo XY
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Dec; 30(12):2693-5. PubMed ID: 21177182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E-cadherin expression in gastroesophageal reflux disease, Barrett's esophagus, and esophageal adenocarcinoma: an immunohistochemical and immunoblot study.
    Swami S; Kumble S; Triadafilopoulos G
    Am J Gastroenterol; 1995 Oct; 90(10):1808-13. PubMed ID: 7572899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased c-myb mRNA expression in Barrett's esophagus and Barrett's-associated adenocarcinoma.
    Brabender J; Lord RV; Danenberg KD; Metzger R; Schneider PM; Park JM; Salonga D; Groshen S; Tsao-Wei DD; DeMeester TR; Hölscher AH; Danenberg PV
    J Surg Res; 2001 Aug; 99(2):301-6. PubMed ID: 11469901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of interleukin 8 gene expression in reflux esophagitis and Barrett's esophagus with antireflux surgery.
    Oh DS; DeMeester SR; Vallbohmer D; Mori R; Kuramochi H; Hagen JA; Lipham J; Danenberg KD; Danenberg PV; Chandrasoma P; DeMeester TR
    Arch Surg; 2007 Jun; 142(6):554-9; discussion 559-60. PubMed ID: 17576892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Esophageal Helicobacter pylori colonization aggravates esophageal injury caused by reflux.
    Chu YX; Wang WH; Dai Y; Teng GG; Wang SJ
    World J Gastroenterol; 2014 Nov; 20(42):15715-26. PubMed ID: 25400455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apoptosis is inhibited early in the dysplasia-carcinoma sequence of Barrett esophagus.
    Katada N; Hinder RA; Smyrk TC; Hirabayashi N; Perdikis G; Lund RJ; Woodward T; Klingler PJ
    Arch Surg; 1997 Jul; 132(7):728-33. PubMed ID: 9230856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in manganese superoxide dismutase expression in the progression from reflux esophagitis to esophageal adenocarcinoma.
    Li Y; Wo JM; Su RR; Ray MB; Martin RC
    Ann Surg Oncol; 2007 Jul; 14(7):2045-55. PubMed ID: 17473952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.
    O'Riordan JM; Abdel-latif MM; Ravi N; McNamara D; Byrne PJ; McDonald GS; Keeling PW; Kelleher D; Reynolds JV
    Am J Gastroenterol; 2005 Jun; 100(6):1257-64. PubMed ID: 15929754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the bile acid receptor FXR in Barrett's esophagus and enhancement of apoptosis by guggulsterone in vitro.
    De Gottardi A; Dumonceau JM; Bruttin F; Vonlaufen A; Morard I; Spahr L; Rubbia-Brandt L; Frossard JL; Dinjens WN; Rabinovitch PS; Hadengue A
    Mol Cancer; 2006 Oct; 5():48. PubMed ID: 17054793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toll-like Receptor 2 Signalling and the Lysosomal Machinery in Barrett's Esophagus.
    Verbeek RE; Siersema PD; Vleggaar FP; Ten Kate FJ; Posthuma G; Souza RF; de Haan J; van Baal JW
    J Gastrointestin Liver Dis; 2016 Sep; 25(3):273-82. PubMed ID: 27689189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association between alcohol and reflux esophagitis, Barrett's esophagus, and esophageal adenocarcinoma.
    Anderson LA; Cantwell MM; Watson RG; Johnston BT; Murphy SJ; Ferguson HR; McGuigan J; Comber H; Reynolds JV; Murray LJ
    Gastroenterology; 2009 Mar; 136(3):799-805. PubMed ID: 19162028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased p53 expression in the malignant transformation of Barrett's esophagus is accompanied by an upward shift of the proliferative compartment.
    Hritz I; Gyorffy H; Molnar B; Lakatos G; Sipos F; Pregun I; Juhasz M; Pronai L; Schaff Z; Tulassay Z; Herszenyi L
    Pathol Oncol Res; 2009 Jun; 15(2):183-92. PubMed ID: 18752044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclooxygenase-2 and inducible nitric oxide synthase gene polymorphisms and risk of reflux esophagitis, Barrett's esophagus, and esophageal adenocarcinoma.
    Ferguson HR; Wild CP; Anderson LA; Murphy SJ; Johnston BT; Murray LJ; Watson RG; McGuigan J; Reynolds JV; Hardie LJ
    Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):727-31. PubMed ID: 18349295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re: Duplication of the muscularis mucosae in Barrett esophagus: an underrecognized feature and its implication for staging of adenocarcinoma.
    Rotimi O
    Am J Surg Pathol; 2008 Dec; 32(12):1913; author reply 1913-4. PubMed ID: 18824891
    [No Abstract]   [Full Text] [Related]  

  • 15. Simultaneous progression of oxidative stress and angiogenesis in malignant transformation of Barrett esophagus.
    Sihvo EI; Ruohtula T; Auvinen MI; Koivistoinen A; Harjula AL; Salo JA
    J Thorac Cardiovasc Surg; 2003 Dec; 126(6):1952-7. PubMed ID: 14688711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycemic index, carbohydrate and fiber intakes and risk of reflux esophagitis, Barrett's esophagus, and esophageal adenocarcinoma.
    Mulholland HG; Cantwell MM; Anderson LA; Johnston BT; Watson RG; Murphy SJ; Ferguson HR; McGuigan J; Reynolds JV; Comber H; Murray LJ
    Cancer Causes Control; 2009 Apr; 20(3):279-88. PubMed ID: 18839322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Does symptomatic gastroesophageal reflux present a risk factor for development of adenocarcinoma of the esophagus?].
    Kellner H; Zoller WG
    Z Gastroenterol; 1999 Oct; 37(10):1071-3. PubMed ID: 10549101
    [No Abstract]   [Full Text] [Related]  

  • 18. Glucocorticoid-induced TNFR family-related receptor (GITR)-expression in tumor infiltrating leucocytes (TILs) is associated with the pathogenesis of esophageal adenocarcinomas with and without Barrett's mucosa.
    von Rahden BH; Kircher S; Kafka M; Stuermer L; Reiber C; Gattenlöhner S; Germer CT; Grimm M
    Cancer Biomark; 2010; 7(6):285-94. PubMed ID: 21694467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations of glutathione S-transferase and matrix metalloproteinase-9 expressions are early events in esophageal carcinogenesis.
    Herszenyi L; Hritz I; Pregun I; Sipos F; Juhasz M; Molnar B; Tulassay Z
    World J Gastroenterol; 2007 Feb; 13(5):676-82. PubMed ID: 17278189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo endoscopic optical coherence tomography of esophagitis, Barrett's esophagus, and adenocarcinoma of the esophagus.
    Jäckle S; Gladkova N; Feldchtein F; Terentieva A; Brand B; Gelikonov G; Gelikonov V; Sergeev A; Fritscher-Ravens A; Freund J; Seitz U; Schröder S; Soehendra N
    Endoscopy; 2000 Oct; 32(10):750-5. PubMed ID: 11068833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.